DARPA is Working on Enhancing Human Senses with Computers


The U.S. Department of Defense is moving forward with its work on brain-computer interfaces (BCIs), with the Defense Advanced Research Projects Agency (DARPA) awarding contracts to five research groups and one private company on Tuesday. BCIs have been around for a while now, but the potential for expanding their capabilities is relatively recent. The primary purpose of BCIs have been developing better neuroprostheses, which is also one of the visions of DARPA's Neural Engineering System Design (NESD) program. Through NESD, DARPA wants to develop high-resolution brain interfaces that could restore and enhance human senses. "The NESD program looks ahead to a future in which advanced neural devices offer improved fidelity, resolution, and precision sensory interface for therapeutic applications," founding NESD program manager Phillip Alvelda said at the announcement, the Singularity Archive reports.

Designer Phillip Lim talks about his new L.A. store, left coast 'contamination' and his first foray into film

Los Angeles Times

Fashion designer Phillip Lim, left, and the interior of his recently opened 3.1 Phillip Lim concept store in the downtown Los Angeles Arts District, right. Fashion designer Phillip Lim, left, and the interior of his recently opened 3.1 Phillip Lim concept store in the downtown Los Angeles Arts District, right. In December 2016, the 3.1 Phillip Lim store on Robertson Boulevard in West Hollywood closed its doors. It was the brand's third brick-and-mortar boutique when it bowed in 2008. This month, a new 5,000-square-foot space (think of it as 3.1 Phillip Lim 2.0) opened nine miles away in downtown Los Angeles' Arts District.

SHOWING HIM UP Schoolkids cook up $2 dose of Shkreli's $750 pill

FOX News

Remember Martin Shkreli, the hedge-fund manager who last year founded Turing Pharmaceuticals, acquired an essential anti-parasitic drug, and quickly jacked up its price 55-fold, from $13.50 to $750 a pill? Well, he's just been shown up by a group of high school chemistry students in Australia who've produced a generic version of Turing's drug, Daraprim, for $2 a pill, reports the Sydney Morning Herald. Led by chemist Alice Williamson and motivated by a dose of disgust, a class of Sydney Grammar School students turned 17 grams of 2,4-chlorophenyl acetonitrile into 3.7 grams of pyrimethamine, the active ingredient in Daraprim. If that sold in the US as Daraprim, it would cost about $100,000 because of the price hike, notes the Australian Broadcasting Corporation. The project was more about principle than anything else, says Williamson. "I thought if we could show that students could make it in the lab with no real training, we could really show how ridiculous this price hike was and that there was no way it could be justified," she tells the Guardian.

No. 15 Colorado leads UCLA, 7-0, in the first quarter

Los Angeles Times

It's tough to tell right now if this UCLA and Colorado game is a defensive gem or just off to an ugly start. Nevertheless, Colorado leads UCLA, 7-0, with 5:49 to play in the first quarter. Tahaan Goodman intercepted his first pass of the season and UCLA took over at its 10-yard line, but the Bruins were unable to convert the turnover into any points because Kenne Olugbode intercepted a pass by Mike Fafaul nine plays later. Olugbode returned the interception 51 yards to UCLA's 23-yard line. Phillip Lindsay rushed one yard for a Buffaloes touchdown to cap the short drive that took eight plays and 2:31.